CAS: 2040295-03-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Pexidartinib (PLX3397) REF: 4Z-K-031070CAS: | - - - | To inquire | Tue 21 May 24 |
 | Pexidartinib Hydrochloride Salt REF: TR-P293640CAS: 2040295-03-0 | - - - | 1,060.00 € | Tue 21 May 24 |
 | Pexidartinib hydrochloride REF: 3D-QGD29503CAS: 2040295-03-0 | Min. 95% | To inquire | Tue 25 Jun 24 |
Ref: 4Z-K-031070
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Pexidartinib Hydrochloride Salt
Controlled ProductCAS:2040295-03-0
Applications Pexidartinib Hydrochloride is RTK inhibitor. It can be used in pharmacological activity, therapeutic use, …
Formula:
C20H15ClF3N5•HCl
Color and Shape:
Off-White Solid
Molecular weight:
454.276
Ref: TR-P293640
| 100mg | 1,060.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Pexidartinib hydrochloride
CAS:2040295-03-0
Pexidartinib hydrochloride is a potent, selective inhibitor of the receptor tyrosine kinases (RTKs) insulin-like growth …
Formula:
C20H16Cl2F3N5
Purity:
Min. 95%
Molecular weight:
454.3 g/mol
Ref: 3D-QGD29503
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024
